Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Spain's Almirall warns of delay in approval for psoriasis drug

November 14, 2017 2:47 PM
17 0

(Reuters) - Spanish pharma company Almirall said on Tuesday it expects the launch of psoriasis treatment drug, Tildrakizumab, in Europe to get delayed by at least six months due to regulatory hurdles.

The company said the anticipated launch of the drug was moved to the end of 2018 or early 2019 from mid-2018.

Read more

Share in social networks:

Comments - 0